ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

NXGL NexGel Inc

2,20
-0,02 (-0,90%)
06 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
NexGel Inc NXGL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,02 -0,90% 2,20 23:16:11
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,13 2,13 2,22 2,20 2,22
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.5.202422:05GLOBENEXGEL to Present at the Aegis Capital Virtual Conference on..
18.4.202414:00GLOBENEXGEL to Present at the Planet MicroCap Showcase: VEGAS..
01.4.202413:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
27.3.202414:00GLOBENEXGEL Reschedules Fourth Quarter and Full Year 2023..
21.3.202414:00GLOBENEXGEL to Report Fourth Quarter and Full Year 2023 Financial..
05.3.202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202414:30GLOBENEXGEL to Present at the iAccess Alpha Best Ideas Spring..
21.2.202422:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21.2.202422:15EDGAR2Form 8-K - Current report
21.2.202422:05GLOBENEXGEL Announces $975,000 Registered Direct Offering Led by..
31.1.202415:05EDGAR2Form 8-K - Current report
18.1.202415:00GLOBENEXGEL to Present at The Microcap Conference, January 30th..
16.1.202422:30EDGAR2Form 8-K - Current report
09.1.202414:30GLOBENEXGEL Subsidiary, CG Converting and Packaging, Begins..
29.12.202322:30EDGAR2Form 8-K - Current report
26.12.202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202322:52EDGAR2Form 8-K - Current report
11.12.202314:15EDGAR2Form 8-K - Current report
11.12.202314:00GLOBENEXGEL Announces Partnership with STADA to Distribute and..
05.12.202314:10EDGAR2Form 8-K - Current report
05.12.202314:00GLOBENEXGEL Acquires Kenkoderm Psoriasis Skincare Line
13.11.202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202323:10EDGAR2Form 8-K - Current report
13.11.202322:05GLOBENEXGEL Reports Record Third Quarter 2023 Revenue of $1.2..
02.11.202314:00GLOBENEXGEL to Report Third Quarter 2023 Financial Results on..
30.10.202313:30EDGAR2Form 8-K - Current report
30.10.202313:00GLOBENEXGEL Secures Supply Agreement with AbbVie
26.9.202315:49GLOBENEXGEL to Participate in the LD Micro Main Event XVI on..
15.9.202300:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.8.202300:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202323:29EDGAR2Form 8-K - Current report
14.8.202322:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:05GLOBENEXGEL Reports Second Quarter 2023 Record Revenue of $1.17..
02.8.202315:00GLOBENEXGEL to Report Second Quarter 2023 Financial Results on..
19.7.202315:10GLOBENEXGEL Partners with Enigma Health to Distribute its Leading..
15.6.202315:00GLOBENEXGEL to Participate in Maxim Group’s Virtual Healthcare..
24.5.202315:00GLOBENEXGEL to Participate in the LD Micro Invitational XIII on..
15.5.202322:05GLOBENEXGEL Reports First Quarter 2023 Financial Results
09.5.202315:15GLOBENEXGEL to Report First Quarter 2023 Financial Results on May..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock